Literature DB >> 32178728

Isoniazid causes heart looping disorder in zebrafish embryos by the induction of oxidative stress.

Jie Ni1, Hongye Wang2, Xiyi Wei2,3, Kangjie Shen2, Yeqin Sha2, Yuxiang Dong2, Yimei Shu2, Xiaojie Wan4, Jingwen Cheng5, Fang Wang6, Yihai Liu7.   

Abstract

BACKGROUND: The cardiotoxicity of isoniazid on zebrafish embryos and its underlying mechanism is unclear.
METHODS: Here, we exposed zebrafish embryos at 4 h post-fertilization to different levels of isoniazid and recorded the morphology and number of malformed and dead embryos under the microscope.
RESULTS: The high concentration of isoniazid group showed more malformed and dead embryos than the low concentration of isoniazid group and control group. The morphology of the heart and its alteration were visualized using transgenic zebrafish (cmlc2: GFP) and confirmed by in situ hybridization. The negative effects of isoniazid on the developing heart were characterized by lower heart rate and more heart looping disorders. Mechanistically, PCR showed decreased expression of heart-specific transcription factors when exposed to isoniazid. Oxidative stress was induced by isoniazid in cardiomyocytes, mediated by decreased activities of catalase and superoxide dismutase, which were rescued by scavengers of reactive oxygen species.
CONCLUSION: In conclusion, this study demonstrated that isoniazid led to heart looping disturbance by the downregulation of cardiac-specific transcription factors and induction of cardiomyocyte apoptosis.

Entities:  

Keywords:  Heart looping disorder; Isoniazid; Oxidative stress

Year:  2020        PMID: 32178728     DOI: 10.1186/s40360-020-0399-2

Source DB:  PubMed          Journal:  BMC Pharmacol Toxicol        ISSN: 2050-6511            Impact factor:   2.483


  1 in total

1.  Impacts of Cetylpyridinium Chloride on the Survival, Development, Behavior, and Oxidative Stress of Early-Life-Stage Zebrafish (Danio rerio).

Authors:  Xuchun Qiu; Michaela Sia Tengbe; Xingyi Xia; Kejun Dong; Chen Chen; Yanhong Shi; Ming Li; Hai Xu; Xiangyang Wu; Kun Chen
Journal:  Antioxidants (Basel)       Date:  2022-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.